Literature DB >> 26146067

[The elevated levels of plasma chemerin and C-reactive protein in patients with acute coronary syndrome].

Zhishan Liang1, Kunwu Yu2, Bangwei Wu2, Yucheng Zhong2, Qiutang Zeng2.   

Abstract

OBJECTIVE: To investigate the plasma levels of chemerin and C-reactive protein (CRP) in the patients with acute coronary syndrome.
METHODS: The plasma levels of chemerin and CRP were respectively measured by ELISA and immune luminescence sandwich assay in 40 patients with acute myocardial infarction (AMI), 40 patients with unstable angina (UA), 40 patients with stable angina (SA) and 40 control patients.
RESULTS: The levels of chemerin and CRP were significantly higher in the AMI and UA groups than in the SA and control groups, and the level of chemerin was significantly higher in the AMI group than in the UA group. The level of chemerin was positively correlated with the level of CRP, fasting glucose and left ventricular end-diastolic diameter, but negatively correlated with left ventricular ejection fraction.
CONCLUSION: The plasma levels of chemerin and CRP are elevated in patients with acute coronary syndrome.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26146067

Source DB:  PubMed          Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi        ISSN: 1007-8738


  2 in total

1.  New Biomarkers as Prognostic Factors for Cardiovascular Complications in Type 2 Diabetic Patients.

Authors:  Hanaa H Ahmed; Wafaa Gh Shousha; Hatem A El-Mezayen; Ibrahim A Emara; Marwa E Hassan
Journal:  Indian J Clin Biochem       Date:  2018-07-17

Review 2.  Role of Chemerin/ChemR23 axis as an emerging therapeutic perspective on obesity-related vascular dysfunction.

Authors:  Yingying Xie; Ling Liu
Journal:  J Transl Med       Date:  2022-03-22       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.